Literature DB >> 30914828

Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population.

Daniel L Polla1,2, Elisa Rahikkala3, Michaela K Bode4, Tuomo Määttä5, Teppo Varilo6, Thyrza Loman1, Anju K Philips6, Mitja Kurki7,8,9, Aarno Palotie7,8,9,10,11, Jarmo Körkkö12, Päivi Vieira13, Kristiina Avela14, Valérie Jacquemin15, Isabelle Pirson15, Marc Abramowicz15, Arjan P M de Brouwer1, Outi Kuismin3,9, Hans van Bokhoven1, Irma Järvelä16.   

Abstract

Intellectual disability (ID), megalencephaly, frontal predominant pachygyria, and seizures, previously called "thin" lissencephaly, are reported to be caused by recessive variants in CRADD. Among five families of different ethnicities identified, one homozygous missense variant, c.509G>A p.(Arg170His), was of Finnish ancestry. Here we report on the phenotypic variability associated for this potential CRADD founder variant in 22 Finnish individuals. Exome sequencing was used to identify candidate genes in Finnish patients presenting with ID. Targeted Sanger sequencing and restriction enzyme analysis were applied to screen for the c.509G>A CRADD variant in cohorts from Finland. Detailed phenotyping and genealogical studies were performed. Twenty two patients were identified with the c.509G>A p.(Arg170His) homozygous variant in CRADD. The majority of the ancestors originated from Northeastern Finland indicating a founder effect. The hallmark of the disease is frontotemporal predominant pachygyria with mild cortical thickening. All patients show ID of variable severity. Aggressive behavior was found in nearly half of the patients, EEG abnormalities in five patients and megalencephaly in three patients. This study provides detailed data about the phenotypic spectrum of patients with lissencephaly due to a CRADD variant that affects function. High inter- and intrafamilial phenotypic heterogeneity was identified in patients with pachygyria caused by the homozygous CRADD founder variant. The phenotype variability suggests that additional genetic and/or environmental factors play a role in the clinical presentation. Since frontotemporal pachygyria is the hallmark of the disease, brain imaging studies are essential to support the molecular diagnosis for individuals with ID and a CRADD variant.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30914828      PMCID: PMC6777631          DOI: 10.1038/s41431-019-0383-8

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  36 in total

Review 1.  Use of population isolates for mapping complex traits.

Authors:  L Peltonen; A Palotie; K Lange
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

Review 2.  Genetic malformations of cortical development.

Authors:  Renzo Guerrini; Carla Marini
Journal:  Exp Brain Res       Date:  2006-05-25       Impact factor: 1.972

Review 3.  Genetic and epigenetic networks in intellectual disabilities.

Authors:  Hans van Bokhoven
Journal:  Annu Rev Genet       Date:  2011-09-09       Impact factor: 16.830

4.  Frontotemporal pachygyria-two new patients.

Authors:  Kristiina Avela; Sanna Toiviainen-Salo; Pirkko Karttunen-Lewandowski; Leena Kauria; Leena Valanne; Riitta Salonen-Kajander
Journal:  Eur J Med Genet       Date:  2012-09-27       Impact factor: 2.708

Review 5.  Genetics and mechanisms leading to human cortical malformations.

Authors:  Delfina M Romero; Nadia Bahi-Buisson; Fiona Francis
Journal:  Semin Cell Dev Biol       Date:  2017-10-11       Impact factor: 7.727

6.  Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism.

Authors:  M Renlund; P Aula; K O Raivio; S Autio; K Sainio; J Rapola; S L Koskela
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

7.  "Salla disease": a new lysosomal storage disorder.

Authors:  P Aula; S Autio; K O Raivio; J Rapola; C J Thodén; S L Koskela; I Yamashina
Journal:  Arch Neurol       Date:  1979-02

8.  Caspase-2 deficiency enhances aging-related traits in mice.

Authors:  Yingpei Zhang; Susan S Padalecki; Asish R Chaudhuri; Eric De Waal; Beth A Goins; Barry Grubbs; Yuji Ikeno; Arlan Richardson; Gregory R Mundy; Brian Herman
Journal:  Mech Ageing Dev       Date:  2006-12-22       Impact factor: 5.432

9.  New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age.

Authors:  Antti Saari; Ulla Sankilampi; Marja-Leena Hannila; Vesa Kiviniemi; Kari Kesseli; Leo Dunkel
Journal:  Ann Med       Date:  2010-09-21       Impact factor: 4.709

10.  Homozygous null variant in CRADD, encoding an adaptor protein that mediates apoptosis, is associated with lissencephaly.

Authors:  Tamar Harel; Nuphar Hacohen; Avraham Shaag; Moshe Gomori; Amihood Singer; Orly Elpeleg; Vardiella Meiner
Journal:  Am J Med Genet A       Date:  2017-07-07       Impact factor: 2.802

View more
  5 in total

1.  Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.

Authors:  Irma Järvelä; Tuomo Määttä; Anushree Acharya; Juha Leppälä; Shalini N Jhangiani; Maria Arvio; Auli Siren; Minna Kankuri-Tammilehto; Hannaleena Kokkonen; Maarit Palomäki; Teppo Varilo; Mary Fang; Trevor D Hadley; Angad Jolly; Tarja Linnankivi; Ritva Paetau; Anni Saarela; Reetta Kälviäinen; Jan Olme; Liz M Nouel-Saied; Diana M Cornejo-Sanchez; Lorida Llaci; James R Lupski; Jennifer E Posey; Suzanne M Leal; Isabelle Schrauwen
Journal:  Hum Genet       Date:  2021-03-12       Impact factor: 4.132

2.  The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects.

Authors:  Hila Fridman; Helger G Yntema; Reedik Mägi; Reidar Andreson; Andres Metspalu; Massimo Mezzavila; Chris Tyler-Smith; Yali Xue; Shai Carmi; Ephrat Levy-Lahad; Christian Gilissen; Han G Brunner
Journal:  Am J Hum Genet       Date:  2021-03-18       Impact factor: 11.043

3.  Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability.

Authors:  Taimoor I Sheikh; Nasim Vasli; Stephen Pastore; Kimia Kharizi; Ricardo Harripaul; Zohreh Fattahi; Shruti Pande; Farooq Naeem; Abrar Hussain; Asif Mir; Omar Islam; Katta Mohan Girisha; Muhammad Irfan; Muhammad Ayub; Christoph Schwarzer; Hossein Najmabadi; Anju Shukla; Valentina C Sladky; Vincent Zoran Braun; Irmina Garcia-Carpio; Andreas Villunger; John B Vincent
Journal:  Transl Psychiatry       Date:  2021-01-05       Impact factor: 6.222

Review 4.  PIDD1 in cell cycle control, sterile inflammation and cell death.

Authors:  Elias S Weiler; Tamas G Szabo; Irmina Garcia-Carpio; Andreas Villunger
Journal:  Biochem Soc Trans       Date:  2022-04-29       Impact factor: 4.919

Review 5.  Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation.

Authors:  Valentina C Sladky; Andreas Villunger
Journal:  Cell Death Differ       Date:  2020-05-15       Impact factor: 15.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.